vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and MEDALLION FINANCIAL CORP (MFIN). Click either name above to swap in a different company.
MEDALLION FINANCIAL CORP is the larger business by last-quarter revenue ($70.6M vs $44.9M, roughly 1.6× AbCellera Biologics Inc.). MEDALLION FINANCIAL CORP runs the higher net margin — 17.3% vs -19.9%, a 37.2% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 25.4%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 15.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
ABCL vs MFIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $70.6M |
| Net Profit | $-8.9M | $12.2M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 29.3% |
| Net Margin | -19.9% | 17.3% |
| Revenue YoY | 788.4% | 25.4% |
| Net Profit YoY | 73.9% | 20.3% |
| EPS (diluted) | $-0.03 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $70.6M | ||
| Q3 25 | $9.0M | $58.7M | ||
| Q2 25 | $17.1M | $62.6M | ||
| Q1 25 | $4.2M | $63.0M | ||
| Q4 24 | $5.0M | $56.3M | ||
| Q3 24 | $6.5M | $53.3M | ||
| Q2 24 | $7.3M | $51.0M | ||
| Q1 24 | $10.0M | $53.3M |
| Q4 25 | $-8.9M | $12.2M | ||
| Q3 25 | $-57.1M | $7.8M | ||
| Q2 25 | $-34.7M | $11.1M | ||
| Q1 25 | $-45.6M | $12.0M | ||
| Q4 24 | — | $10.1M | ||
| Q3 24 | $-51.1M | $8.6M | ||
| Q2 24 | $-36.9M | $7.1M | ||
| Q1 24 | $-40.6M | $10.0M |
| Q4 25 | -63.7% | 29.3% | ||
| Q3 25 | -851.8% | 33.2% | ||
| Q2 25 | -290.2% | 31.1% | ||
| Q1 25 | -1479.6% | 32.1% | ||
| Q4 24 | — | 32.8% | ||
| Q3 24 | -1439.4% | 26.6% | ||
| Q2 24 | -1276.2% | 24.3% | ||
| Q1 24 | -551.5% | 33.6% |
| Q4 25 | -19.9% | 17.3% | ||
| Q3 25 | -637.8% | 13.2% | ||
| Q2 25 | -203.3% | 17.7% | ||
| Q1 25 | -1077.2% | 19.1% | ||
| Q4 24 | — | 18.0% | ||
| Q3 24 | -785.4% | 16.1% | ||
| Q2 24 | -504.3% | 13.9% | ||
| Q1 24 | -408.0% | 18.8% |
| Q4 25 | $-0.03 | $0.50 | ||
| Q3 25 | $-0.19 | $0.32 | ||
| Q2 25 | $-0.12 | $0.46 | ||
| Q1 25 | $-0.15 | $0.50 | ||
| Q4 24 | — | $0.43 | ||
| Q3 24 | $-0.17 | $0.37 | ||
| Q2 24 | $-0.13 | $0.30 | ||
| Q1 24 | $-0.14 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $136.3M |
| Total DebtLower is stronger | — | $216.0M |
| Stockholders' EquityBook value | $966.9M | $408.6M |
| Total Assets | $1.4B | $3.0B |
| Debt / EquityLower = less leverage | — | 0.53× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $136.3M | ||
| Q3 25 | $83.2M | $72.5M | ||
| Q2 25 | $92.4M | $110.4M | ||
| Q1 25 | $159.3M | $131.5M | ||
| Q4 24 | $156.3M | $98.2M | ||
| Q3 24 | $126.6M | $120.6M | ||
| Q2 24 | $148.3M | $87.7M | ||
| Q1 24 | $123.6M | $54.8M |
| Q4 25 | — | $216.0M | ||
| Q3 25 | — | $215.7M | ||
| Q2 25 | — | $199.9M | ||
| Q1 25 | — | $199.7M | ||
| Q4 24 | — | $232.2M | ||
| Q3 24 | — | $232.0M | ||
| Q2 24 | — | $230.8M | ||
| Q1 24 | — | $225.6M |
| Q4 25 | $966.9M | $408.6M | ||
| Q3 25 | $964.0M | $397.4M | ||
| Q2 25 | $1.0B | $389.9M | ||
| Q1 25 | $1.0B | $380.2M | ||
| Q4 24 | $1.1B | $370.2M | ||
| Q3 24 | $1.1B | $362.4M | ||
| Q2 24 | $1.1B | $354.0M | ||
| Q1 24 | $1.1B | $349.0M |
| Q4 25 | $1.4B | $3.0B | ||
| Q3 25 | $1.4B | $2.9B | ||
| Q2 25 | $1.4B | $2.9B | ||
| Q1 25 | $1.3B | $2.8B | ||
| Q4 24 | $1.4B | $2.9B | ||
| Q3 24 | $1.4B | $2.9B | ||
| Q2 24 | $1.4B | $2.8B | ||
| Q1 24 | $1.5B | $2.6B |
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.63× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.65× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $126.3M |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | 10.35× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $126.3M | ||
| Q3 25 | $-52.6M | $67.0M | ||
| Q2 25 | $-32.4M | $-10.7M | ||
| Q1 25 | $-11.6M | $36.3M | ||
| Q4 24 | $-108.6M | $108.7M | ||
| Q3 24 | $-28.9M | $24.6M | ||
| Q2 24 | $-30.0M | $27.6M | ||
| Q1 24 | $-41.7M | $32.3M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | — | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-22.2M | — | ||
| Q4 24 | $-187.0M | — | ||
| Q3 24 | $-47.4M | — | ||
| Q2 24 | $-50.1M | — | ||
| Q1 24 | $-65.8M | — |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | — | ||
| Q2 25 | -267.9% | — | ||
| Q1 25 | -524.0% | — | ||
| Q4 24 | -3702.8% | — | ||
| Q3 24 | -728.4% | — | ||
| Q2 24 | -683.8% | — | ||
| Q1 24 | -661.5% | — |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | — | ||
| Q2 25 | 78.2% | — | ||
| Q1 25 | 251.1% | — | ||
| Q4 24 | 1552.7% | — | ||
| Q3 24 | 284.6% | — | ||
| Q2 24 | 274.6% | — | ||
| Q1 24 | 242.5% | — |
| Q4 25 | — | 10.35× | ||
| Q3 25 | — | 8.63× | ||
| Q2 25 | — | -0.97× | ||
| Q1 25 | — | 3.02× | ||
| Q4 24 | — | 10.72× | ||
| Q3 24 | — | 2.86× | ||
| Q2 24 | — | 3.89× | ||
| Q1 24 | — | 3.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
